Advanced Statistics in Regulatory Critical Clinical Initiatives von Wei (Hrsg.) Zhang

CHF 210.00 inkl. MwSt.
ISBN: 978-0-367-56178-9
Einband: Fester Einband
Verfügbarkeit: Lieferbar in ca. 10-20 Arbeitstagen
+ -

This book is focused on the critical clinical initiatives introduced by the 21st Century Cure Act passed by the United States Congress in December 2016. The book covers everything from the outline of the initiatives to analysis on the effect on biopharmaceutical research and development.

This book is focused on the critical clinical initiatives introduced by the 21st Century Cure Act passed by the United States Congress in December 2016. The book covers everything from the outline of the initiatives to analysis on the effect on biopharmaceutical research and development.

AutorZhang, Wei (Hrsg.) / Yan, Fangrong (Hrsg.) / Chen, Feng (Hrsg.) / Chow, Shein-Chung (Hrsg.)
EinbandFester Einband
Erscheinungsjahr2022
Seitenangabe307 S.
LieferstatusLieferbar in ca. 10-20 Arbeitstagen
AusgabekennzeichenEnglisch
AbbildungenFarb., s/w. Abb.
MasseH25.4 cm x B17.8 cm 703 g
CoverlagChapman and Hall/CRC (Imprint/Brand)
Auflage1. A.
ReiheChapman & Hall/CRC Biostatistics Series
VerlagTaylor and Francis

Alle Bände der Reihe "Chapman & Hall/CRC Biostatistics Series"

Über den Autor Wei (Hrsg.) Zhang

WEI ZHANG, PHD, is Professor of Chemistry and Director of the Center for Green Chemistry at the University of Massachusetts Boston. He is known for research work in organic synthesis, medicinal chemistry, and green chemistry. He received the 2015 International Fluorous Technology Award and is one of the top three most published authors in fluorous chemistry. BERKELEY W. CUE, PHD, is President and Founder of BWC Pharma Consulting LLC, a consultancy specializing in pharmaceutical sciences and green chemistry, and Adjunct Professor of Chemistry at the University of Massachusetts Boston.

Weitere Titel von Wei (Hrsg.) Zhang